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Abstract
The use of mobile health technologies (mHealth) to ameliorate HIV care has considerably risen in low- and
middle-income countries (LMICs) since 2010. Yet, the discrepancies in the results of accompanying studies
warrant an updated and systematic consolidation of all available evidence. We report a systematic review of
studies testing whether text/image messages, interactive voice response reminders, or calls promote adherence
and retention to antiretroviral therapy (ART) in LMICs. We systematically compiled studies published in
English until June 2018 from PubMed/Medline, Web of Science, WHO database, ProQuest Dissertations and
Theses, and manual search. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) 2009 and used frequency analysis to assess reported findings. In total, we compiled 35 published
articles: 27 completed studies and 8 protocols. Among the main 27 studies, 17 examine adherence, 5 retention,
and 5 both measures. Results indicate that 56% report positive and statistically significantly impacts of mHealth
on primary outcomes, the remaining 44% report insignificant results. While 41% of studies found a positive and
significant effect for adherence, only 12% improved retention. The evidence shows ambiguous results (with
high variability) about the effectiveness of mobile phone-assisted mHealth interventions to boost adherence and
retention to ART. The literature also points to short follow-up periods, small samples, and limited geographical
coverage. Hence, future research should focus on evaluating longer interventions with more patients spread
across wider areas to address whether mHealth can be effectively used in LMICs.
Keywords: HIV/AIDS patient care, mobile health technology (mHealth), antiretroviral treatment, short mes-
sage service, low- and middle-income countries
Introduction
Adherence and retention to antiretroviral therapy(ART) are difficult to achieve for people living with
human immunodeficiency virus (PLHIV) in particular in
low- and middle-income countries (LMICs).1 PLHIV often
face strong social and economic restrictions preventing them
from sustaining ART. The main challenges in adherence and
retention result from income losses due to lay-offs and high
travel costs to medical centers that are likely to intensify
discrimination, stigma, and disinformation.1–3 For instance,
about 22.5% of patients in sub-Saharan Africa (SSA) dis-
continue ART within the first 10 months, and 56% are lost to
follow-up or die within the first 2 years of treatment.4–6
To respond to this emergency, the World Health Organi-
zation (WHO) fosters the use of mobile health technologies
(mHealth) in LMICs.7 Mobile phones facilitate instant
communication across long distances that may encourage
patients to adhere and retain to quality care.2,8,9 In particular,
systems of short message services (SMS) can remind patients
to take their pills, to attend refill appointments, and to retain
in treatment. When SMS are used effectively, they comprise
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a low-barrier and low-cost intervention that yields cost-
efficient impacts on the health of PLHIV.10 These potentially
attractive benefits have stimulated numerous assessments to
test whether SMS reminders can indeed improve adherence
and retention to medical protocols in LMICs.7,11
Yet, there is scattered evidence about the effectiveness of
SMS and other mobile phone-assisted mHealth interventions
in LMICs despite their appealing features. One group of in-
terventions shows that mobile reminders effectively promote
adherence and retention to ART,12,13 but a number of studies
find insignificant impacts.14,15 The high variability across
findings and the considerable number of recent studies war-
rant the compilation of a comprehensive systematic review to
organize and report the overall designs and results of SMS
interventions for PLHIV in LMICs since systematic reviews
are important to inform health policies and future research by
establishing a global assessment of the full evidence.16–18
This article contributes to the literature by presenting an
updated systematic review of primary studies about mobile
phone-assisted mHealth interventions that use SMS remind-
ers, interactive voice response (IVR) reminders, or calling to
promote adherence and retention to ART in LMICs. We have
also included studies in the analysis that combine SMS, IVR,
or calling with other support, such as counseling. We have
opted for this combination of interventions since we consider
that it provides the most comprehensive overview of the
scope and value added of mobile phone assisted mHealth
interventions in LMICs. We focus on LMICs for two reasons:
first, existing systematic reviews consolidating the evidence
of mobile phone interventions on adherence and retention to
ART focus on developed countries or evaluate general areas
of health instead.19–23 Yet, given the high pace in the im-
plementation and publication of recent studies, a review for
LMICs becomes of paramount importance to assess the state
of the art of the role of mobile phone interventions for ART.
Second, PLHIV in LMICs suffer from the disease and ART in
fundamentally different forms compared to patients in de-
veloped countries. Thus, this systematic review can serve as
an indication for future research and public programs in-
volving mHealth in LMICs.
Materials and Methods
We conducted a systematic literature search of studies
assessing the use of mobile phone technology to promote
adherence and retention to ART in LMICs. We used the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses 2009 (PRISMA 2009)24 when retrieving potentially
relevant studies and when integrating and reporting the evi-
dence based on inclusion and exclusion criteria25 (see com-
plete checklist in Supplementary Appendix SA1 available
online).
Search strategy
The study used a systematic web search to review primary
studies on mobile phone-assisted mHealth interventions and
ART in LMICs. The inclusion criteria are based on the Po-
pulation Intervention Comparison Outcome (PICO) model.
As shown in Table 1, we formulated the search strategy using
five terms/categories. Terms within sets are connected via
OR, and terms between sets are connected using AND. All
sets search the title, abstract, and keywords of articles. Fur-
ther details are found in Supplementary Appendix SA2
(available online) that displays the general search used.
We screened four web-based sources and included a
manual-based approach to identify studies published until
June 2018. We searched for primary studies in the following
databases: PubMed, Web of Science, ProQuest Dissertations
and Theses, and the WHO Global Health Library. To yield
database specific results, the general query was adjusted for
ProQuest Dissertations and Theses and the WHO Global
Health Library. In the additional manual search, we used the
reference lists of the articles included in the most recent
primary empirical studies.
Study selection
A two-stage selection process was chosen to determine
eligibility. The first stage selected articles using title
screening. Additional screening was applied using similarity
of keywords in cases where articles had unclear titles. During
the second-stage screening process, we reviewed abstracts
and full texts (when necessary). More specifically, in the
second-stage, we screened for articles that satisfied the fol-
lowing criteria:
1. Target outcome: adherence or retention to ART among
PLHIV.
2. Empirical studies with interventions using electronic
text/image messaging, IVR or call (as stand-alone or
combined with other support such as counseling) for
adult patients (>15 years).
3. Quantitative report of (at least) one outcome from the
following three: (i) adherence (self-report, pill count,
electronic drug monitoring device, or pharmacy refill),
(ii) retention (missed visits or patient remains on
ART), and/or (iii) biological (viral load, CD4+ count,
or biomarker).
4. English articles published until June 2018 in LMICs.26
Data extraction
Two reviewers (B.A.D. and L.A.-M.) independently con-
ducted the search, the examination of eligibility, and the
extraction of data. We used a standardized Microsoft Excel
data template. Individually and separately, the two reviewers
collected the following information about each study: pub-
lication features (year of publication, outlet/publisher, study
country, web source), characteristics of the design [length of
intervention, sample size, study type such as randomized
controlled trial (RCT)], targeted participants, intervention
(text/image/voice, language and frequency), outcome char-
acteristics (adherence and/or retention), and intervention re-
sults (sign, magnitude, and significance of the estimates).
Assessment of risk of bias
We evaluated the methodological risk of bias (ROB) of
compiled studies in accordance with the Cochrane Handbook
for Systematic Reviews of Interventions.27 The process in-
cluded that one reviewer (B.A.D.) evaluated the ROB and a
second reviewer (L.A.-M.) independently reviewed it as well.
All discrepancies were resolved with discussion and con-
sensus. For the ROB, we report random sequence generation,
allocation concealment, blinding, incomplete outcome data,
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selective outcome reporting, and other sources of bias for
RCTs. In addition, we included intention to treat analysis (ITT)
for the incomplete outcome data of the ROB domain: defined
as participants being assessed based on their initial treatment
assignment (regardless of treated arm).28 We develop the ROB
only for RCT studies. We do not conduct the ROB assessment
for other types of interventions as there is no consensus on the
quality assessment for non-RCT studies.27 RCTs were cate-
gorized at highest ROB when rated high for the random se-
quence generation and allocation concealment domains.
Analysis of data
Our analytical approach uses a descriptive summary of
the articles included in the systematic review. To develop the
analysis of the data, we performed a frequency analysis of the
following characteristics: general characteristics, interven-
tion characteristics, as well as the results/conclusions of the
intervention. Although interesting, we decided not to conduct
a meta-analysis given the eminent heterogeneities in the
study characteristics, missing data on designs, intervention
durations, and missing p values in the reported outcomes.
Results
This section presents the results of the systematic review.
We divide the findings into: (1) selection of studies and data
extraction, (2) characteristics of studies, (3) ROB, and (4)
overall assessment of the effectiveness of mHealth inter-
ventions. The main assessment examines the 27 completed
studies using frequency analysis.
Selection of studies and data extraction
The selection and extraction of data were developed by
two independent and separate reviewers (B.A.D. and L.A.-M.).
Following the two-stage selection process, the first stage
identified a total of 195 studies using title screening. Most
first-stage studies were irrelevant as we used an inclusive
search query that resulted in a large set of false hits. Thus, we
conducted the second-stage screening process by reviewing
abstracts and full texts (when necessary). Figure 1 shows the
flowchart and number of studies identified and selected
across the two-stage selection process.
The screening of titles and abstracts in the second stage
excluded 102 articles that were selected in the first stage. The
duplication of studies was also common across electronic
databases, so only 75 peer-reviewed articles remained in our
systematic review after removing duplicates. In addition, we
dropped another 49 studies after the careful assessment of full
texts. Supplementary Appendix SA3 (available online) pro-
vides a complete record of excluded studies with a justifi-
cation for their exclusion. The subsequent manual search
identified 27 additional studies through citation tracking.
After review of the abstracts and full texts, only nine more
articles were added as they matched the inclusion criteria.
Table 2 presents the number of studies retrieved and selected
per database. At the end of the process, we identified and
selected a final sample of 27 completed studies and 8 pro-
tocols. Table 3 presents detailed information of the included
articles. Note that the eight protocols are excluded from our
analysis as we focus on after-intervention estimates.
Characteristics of the studies
In terms of scope, the 27 completed studies were carried
out in Africa, Asia, and Latin America. Articles on Africa
have the highest share reaching about 63%. Twelve studies
were performed in Cameroon, Kenya, South Africa, and
Uganda (three in each country), while Mozambique and
Swaziland account for four articles (two each), and one was
done in Nigeria. This strong focus on Africa is consistent with
the high prevalence of HIV on the continent; more than 3.9
million children and adults in SSA undergo ART and the
management of the HIV epidemic is a priority on the inter-
national health agenda.29,30 Meanwhile, Asian countries ac-
counted for 33% of the 27 articles: 8 articles tested
interventions in China and India (4 in each country) and a
single article shows results for Pakistan. Only one study was
conducted in Latin America (Brazil).
The two most common interventions investigate the im-
pact of: (1) standardized SMS messages (text, image, or
both), or (2) IVR reminders. Nearly 90% (n = 24) of the
studies investigate standardized SMS messages, of which
four are combined with IVR, calling or counseling. One study
in China combined calls with bimonthly nurse home visits.31
Ownership of a mobile phone was not an eligibility criterion
in two RCTs that provided mobile phones (Rural Kenya and
South India).13,14 Only two of the RCTs assessed IVR alone
with one of them finding no statistically significant impact.
Moreover, we find high variation in terms of the time period,
during which patients received the intervention. The
Table 1. Terms for the Literature Search
Database Sets Categories Terms
PubMed, Web of Science
(ISI Web of Knowledge),
ProQuest Dissertations
& Theses, WHO Global
Health Library
Set 1 Mobile phone Mobile phone; *mPhone; cellular phone; text message; cell
phone; SMS; short message service; simple message
service; pager; two*way electronic message* system;
voice call *; IVR; interactive voice *
Set 2 HIV HIV*; *HIV; AIDS; people living with HIV*AIDS; human
immunodeficiency virus; PLWHA
Set 3 Retention or adherence Adheren*; medication * adherence; retention; medication *
retention; CD4; biomarker; viral load
Set 4 Antiretroviral therapy *ART; antiretroviral therapy; highly active antiretroviral
therapy; ARV
Set 5 Region/setting low income *; middle income *; low* and middle * income
countr*; developing countr*
The asterisk (*) is added to the search terms as a placeholder for any unknown or wildcard term.
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minimum time that patients received messages was 1 month
(implemented in three studies in North Western Cameroon,
Southern India, and Indian West Bengal).32–34 A maximum
period of 24 months was used for a study on health care
delivery in South India.14 The average evaluation period was
9 months. Assessing the RCT studies separately, we find a
similar picture of short-term interventions except for one
study.14 In terms of evaluation designs, 74% are RCTs
(n = 20), 7.4% are cohort studies (n = 2), and 7.4% use a
quasiexperimental design (n= 2). The remaining 11.2% in-
clude controlled studies (n= 3) that use before–after, cross
sectional, or pilot designs.
The messages were formulated to remind patients of medi-
cation, appointments, education, and/or counseling offers. The
content was often generic (10 of 27 studies). This approach is
supported with evidence from Peru examining the perceptions
of PLHIV about message content and suggesting that concise,
general messages are the preferred choice.35 In contrast, in
three reviewed studies, message content was personalized, in-
cluding the name of the recipient. In 14 of the 27 studies, the
authors did not explicitly specify the content of the messages.
Several examples of message content are presented in Fig. 2.
Regarding the language of the messages, in 17 studies the
message reminders were sent in the local or preferred language
of the participant. This finding builds on earlier research
showing that illiteracy is negatively associated with impacts of
message reminders.36
The geographical coverage of the interventions is not
uniform across studies but tends to be restricted. Nearly one
in three studies focuses on urban areas. It was only in Africa
that also interventions in rural areas were studied (7 of the 17
studies). The 10 studies from Asia and Latin America focus
merely on urban areas. No study uses a nationally represen-
tative sampling strategy in the evaluation design. But as
complementary results, we identify two published protocols
that aim at addressing this weakness. First, L’Engle et al.37
published a protocol to conduct a 3-year intervention with
1600 patients in 5-regions of Ghana. But this study was
suspended before launching the intervention due to un-
certainties about the success of implementation. Second,
there is one published protocol implementing a nationwide
study with a representative sample in Burkina Faso.38 This
study rests on a sample of more than 3800 patients in a five-
arm RCT over a 2-year period.
Our findings show high variability in the number of par-
ticipants and evaluation methods but similarities in the age of
FIG. 1. Flowchart of literature selec-
tion process.
Table 2. Literature Search Results by Database
Database
Results
retrieved
Results
selected
PubMed 115 16 (3)
Web of Science (ISI Web
of Knowledge)
24 2
ProQuest Dissertations & Theses 15 0
WHO Global Health Library 41 1 (4)
Hand-searching/citation tracing 27 8 (1)
Total 222 27 (8)
Figures in parentheses stand for protocol studies. FIG. 2. Examples of message reminders sent to patients.
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the target group. The largest study included 2255 partici-
pants, but about 74% of the studies had less than 500 par-
ticipants with a median of 196. Recent studies argue that
research about adherence and retention to ART require large
sample sizes as well as sustained periods of the mHealth
intervention.6,38 However, more than half of the studies in-
cluded in the review only assesses short-run impacts in small
samples. There are three exceptions (studies in Mozambique,
South Africa, and Swaziland) that on average assess 2152
patients over a 12 months period.39–41 Across the 20 RCTs,
only 2 use a large sample and 9 have less than the median
sample size of the 27 studies selected in the present review. In
contrast, the review finds similarities across studies in the
minimum age of the participants. Most interventions targeted
participants older than 18 years, who were relatively ART-
naive (no more than 3 months), and in possession of a mobile
phone. Two studies included participants from the age of 15
years (South Africa and Uganda).42,43 In five articles, the age
of the participants was not specified.
Regarding publication dates, we find studies from de-
veloped countries since the early 2000s.9 For LMICs, the
first two studies for China and Kenya were published in
2010.31,44 Both studies were performed in three different
HIV clinics with different economic conditions. In Kenya, a
total of 538 patients were randomly assigned to a control
and treatment group, while the intervention in China only
included 116 patients. Over the years, the number of inter-
ventions has been increasing (review details in Table 3).
The median article appeared in 2014 and most articles were
published in 2017.
ROB in the identified studies
Figure 3 presents a summary of the ROB items for the
RCTs. Exactly 85% of the 20 articles that use RCTs were
rated having low risk of random sequence generation bias.
Most studies applied computer-assisted randomization or
minimization. The remaining three studies (15%) had unclear
risk of random sequence generation. For allocation conceal-
ment, we find a similar pattern: 80% of the studies were at
low risk, while the rest at an unclear level. Importantly, none
of the studies was rated at high risk in these two domains.
However, blinding of participants, medical staff, and asses-
sors was not done across studies. Performance bias was rated
at high risk for most studies (85%). Similar results are ob-
served for detection bias; yet, four studies had a low bias in
this domain. The other domains of ROB were rated at low risk
for 70–95% of the studies.
Detailed ROB assessments for each reviewed study are
provided in Supplementary Appendix SA4 (available on-
line); 13 studies were rated with low risk in all domains
except for blinding, which was rated at high risk. For the
remaining seven RCTs, at least one item of selection bias was
unclear.31,32,45–47 Two studies did not show ITT estimates12,47
and the estimation method was unclear in one other study.46
This latter study was also rated with high attrition bias. No other
study obtained a high-risk score in attrition bias. Moreover, one
study scored high in risk of selective reporting bias48 whereas
five studies showed an unclear bias.12,32,45,49,50 Other dimen-
sions of bias, such as conflict of interest or funding, were un-
clear in two studies,32,42 while all the remaining studies had low
ROB results.
Did SMS or IVR promote adherence and retention?
Of the 27 published studies included in our systematic review,
17 (63%) examined the utilization of mobile technology (SMS,
voice or both) on adherence while only 5 (18.5%) assessed re-
tention. Another 5 (18.5%) of the studies evaluate both adher-
ence and retention to ART. Adherence was typically defined
using self-reports, pill counts, an electronic medication event
monitoring system, and/or suppression of viral load. In turn,
retention was measured as loss to follow-up (with and without
identifiable cause) or the rate of scheduled visits missed.
In total, 56% of the studies found that mobile technology had
positive and statistically significant impacts on adherence and
retention (n= 15). In contrast, 44% report that using mobile
phones was not effective to ameliorate any of these two out-
comes in PLHIV (n= 12). If we examine each outcome sepa-
rately, for adherence, 41% find positive and significant results
and 28% insignificant impacts, while 12% of the studies re-
ported positive retention effects and 19% insignificant effects.
Note that we have 5 studies that reported both adherence and
retention resulting in 10 outcomes plus the 22 studies that re-
ported either retention or adherence. This results in a total of 32
possible outcomes: 22 adherence and 10 retention outcomes, of
which 13 and 4 found positive and statistically significant ef-
fects, respectively. Overall, the systematic review shows that
only about one in two studies has achieved the objective of
measurable improvements in ART revealing high variability
across studies and outcomes. The findings further suggest that
mobile phone-assisted mHealth has higher impacts on mea-
sures of adherence than retention. Table 4 presents the results
for the main outcomes of the systematic review. Since across
studies, a host of different outcome indicators has been chosen,
we can only speculate that identifiable impacts might depend, at
least to some extent, on the choice of outcome.
Furthermore, the previous literature argues that the lack of
positive and statistically significant impacts is linked to the
small number of completed RCTs.51 Notice, however, that
RCT designs represent the dominant evaluation method in
our review (74%, 20 of 27 studies). Thus, after restricting our
sample to RCT studies as a qualitative robustness test, we find
that 60% (12 of 20) show a positive and statistically signifi-
cant increase of adherence and/or retention to ART. This
result is consistent with the findings obtained using the whole
sample. There is only a 4-percentage point difference in favor
of the randomized studies.
Discussion
This article conducts a systematic review of mobile phone-
assisted mHealth interventions designed to improve adher-
ence and retention to ART in LMICs. Informed by the
PRISMA 2009 Guidelines, we systematically included
studies from PubMed/Medline, Web of Science, WHO da-
tabase, ProQuest Dissertations and Theses, and manual
search published in English language until June 2018 (in-
clusive). We used frequency analysis of the collected data to
systematically examine the results of the reported outcomes.
We selected a total of 35 studies divided between 27 com-
pleted evaluations with published results and 8 protocols of
ongoing interventions. Among the 27 finished studies 17
(63%) investigated adherence to ART, 5 studies (18.5%)
focused on retention in care, and 5 (18.5%) jointly assessed
adherence and retention; in terms of the geographical
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distribution, 17 studies were carried out in SSA, 9 in Asia,
and only 1 in Latin America.
We show that 56% of the 27 completed studies indicate that
mobile technology positively and significantly impacts adher-
ence and retention to ART. These findings are robust to ex-
cluding nonrandomized studies, which shows that results are
robust to design or program implementation. By outcome var-
iable, mobile phone-assisted mHealth is effective in increasing
adherence (41%) compared to retention (12%). Thus, the evi-
dence suggests that identifiable impacts of SMS, IVR, and call
for ART might be found only along some dimensions and
consequently also depend on the choice of outcome variable.
We find high variability in the characteristics of the interven-
tions. Moreover, most studies comprised short analysis periods
and small samples covering highly restricted geographical areas.
A serious downside is that not a single study achieves national
representativeness. Hence, the reviewed evidence is still rather
ambiguous about the effectiveness of mobile phone-assisted
mHealth interventions for PLHIV in LMICs. Future research in
the area must expand the study duration and sample size to
achieve better representativeness and gauge possible (new) di-
mensions of impact. An existing effort is presented in the pub-
lished protocol by Wagner et al. for Burkina Faso.38
Does our systematic review agrees or disagrees
with the wider evidence?
Comparing the results from the present systematic review
with previous work confirms both, namely that (1) the impact
of SMS and IVR interventions is overall ambiguous, and that
(2) there is only scarce evidence of systematic reviews for
LMICs. First, a Cochrane review pooling two studies for
Kenya finds that SMS messages did not reduce the risk for
nonadherence.19 These two studies are also included in our
systematic review.13,44 Second, Govindasamy et al.21 provide
a review of 24 studies published between 2004 and 2013
about retention in pre-ART care and initiation of ART from
various interventions (not only mHealth) in LMICs. Al-
though that review shows that several interventions produced
favorable outcomes in observational cohort studies, it has two
caveats compared to our systematic review: (1) it suffers
from unclear ROB, and (2) an incomprehensive selection of
studies published until 2013. We have included 12 studies
published until 2013, however, none of these studies was
included in the review by Govindasamy et al.21
Kanters et al.52 show in a meta-analytical research that
multiple interventions are significantly better than single in-
terventions to improve adherence. Compared to standard care
alone, SMS interventions had positive impacts globally and
when only considering LMICs. Overall, the consolidated
evidence suggests that while (multiple) interventions can
improve adherence and viral suppression, their impact is
modest, fades over time, and differs across countries. In
similar vein, recent qualitative evidence from India suggests
that mobile phone-based counseling for HIV-positive women
is well perceived.53 It is argued that calls might be more
acceptable in accompanying ART than SMS.
In sum, our review combines evidence from existing re-
views with new studies that were not considered in previous
systematic reviews on LMICs. We close an evidence gap as
FIG. 3. Summary of risk of bias items across included studies (%).
Table 4. Classification of Outcomes from the Reviewed Articles
Outcome Insignificant impact Significant positive impact Total no. of articles (%)
Retention 3 [1] 2 [2] 5 (18.5%); [3 (15%)]
Adherence 6 [4] 11 [8] 17 (63%); [12 (60%)]
Retention and adherence 3 [3] 2 [2] 5 (18.5%); [5 (25%)]
Total 12 [8] 15 [12] 27 (100%); [20 (100)]
Figures in square brackets stand for RCTs.
RCT, randomized controlled trial.
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there is scarce evidence rigorously compiling the existing
primary studies on mobile phone-assisted mHealth inter-
ventions for PLHIV outside developed countries.
In addition, our results can be more readily compared to
current findings for developed countries. A recent review of
35 studies carried out in developed countries, including 13
RCTs from the United States, found unclear results for in-
terventions evaluating a wider scope of sexually transmitted
diseases and health management (prevention, detection,
treatment, and knowledge).28 Another systematic review of
34 studies (mainly United States, n = 15) indicates that text
message interventions improve adherence rates, but this re-
view includes different methods of evaluation and diseases
(i.e., asthma, diabetes, heart problems, and schizophrenia).54
It evaluated only six studies involving patients in ART. Si-
milarly, Chaiyachati et al.,9 in a review composed of 20
studies mainly from North America, found high variability in
the effectiveness of a combination of interventions that in-
clude (1) adherence reminders, (2) cognitive-behavioral in-
terventions, (3) education, (4) treatment supporters, and (5)
directly observed therapy. Although these five interventions
can improve adherence to ART, impacts are not coherent
across settings.9 Similarly, Guy et al.20 find that SMS re-
minders reduce nonattendance rates and improve medical
attendance in a review of 18 studies (mostly) in European
countries that were published between 2006 and 2010.
Our systematic review differs in three fundamental points
from another systematic review of 28 interventions showing
that mHealth provides positive impacts on HIV-outcomes.55
First, our research focuses exclusively on LMICs. In contrast,
Cooper et al.55 jointly assess evidence from high- and low-
income settings. Most of our primary studies originate from
interventions in Africa (63%), while the majority of their
studies are from North America (56%). Second and contrary to
the earlier review, our review assesses not only adherence but
also retention. Third, we extend the timeframe to June 2018 and
thus expand it from the earlier end date of October 2016.
After a careful analysis of the existing literature we found
that available reviews are restricted to specific types of pro-
gram implementation,28,54 or include only one of the two
primary outcomes.9,20 Moreover, as outlined above, existing
studies about LMICs tend to be limited in scope.19,21 Our
review differs from previous work as we include all quanti-
tative study designs and the two most commonly assessed
outcomes (retention and adherence) of ART interventions.
Limitations
Our review has three main limitations. First, we only
compile studies written in English due to challenges review-
ing studies in other languages. Including articles in other
languages may provide a more holistic representation of
mHealth activities. Notably, countries speaking other lan-
guages may show different responses to mobile phone inter-
ventions. Yet, since English is the main scientific language,
we expect that we covered all major studies. Second, we ex-
clusively included studies from LMICs. We took that decision
because the health care system and situation of PLHIV are
very different in LMICs compared to high-income countries,
and we included a short comparison between our study and
related systematic reviews for developed countries. We are
aware that recently three innovative mHealth interventions for
PLHIV have been implemented in the United States using (1)
a smartphone app to connect patients to clinic staff and edu-
cational resources,56 (2) social media,57 and (3) daily mes-
sages plus counseling.58
Finally, we did not conduct a meta-analysis because of the
large heterogeneity across studies. We identified many differ-
ent study designs, intervention types, durations, various mea-
sures for similar outcomes, and, in particular, we found that
numerous p-values for the reported outcomes were missing.
Conclusions
We systematically review studies testing mHealth inter-
ventions (SMS, IVR, calls) on health outcomes of PLHIV in
LMICs that were published until June 2018. Previous sys-
tematic reviews concentrate on developed countries,54 are
restricted to specific types of program implementation,28,54
are limited to RCT designs,19 or include only one of our two
primary outcomes.9,20 There is scarce evidence rigorously
compiling the existing primary studies on mobile phone-
assisted mHealth interventions outside developed countries.
To the best of our knowledge, only one review was conducted
for LMICs assessing retention in pre-ART care and initiation
of ART from various interventions (not only mHealth) up to
the year 2013.21 Thus, our study expands the timeframe and
results by including the most recent studies for LMICs (until
June 2018) and also covers a larger set of outcomes and a
number of new studies that are not considered in previous
systematic reviews on LMICs.
The consolidated evidence shows ambiguous results (with
high variability) about the effectiveness of mobile phone-
assisted mHealth to boost adherence and retention to ART. The
review also points to short follow-up periods, small samples,
and narrow geographical areas, although we highlight the
current intervention in Burkina Faso.38 Hence, evaluating
longer interventions and larger number of patients across wider
national spaces should be a priority of future research. The
latter may resolve whether mobile phone-assisted mHealth
interventions can be effectively used for PLHIV in LMICs.
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